| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $98K | +9745.0% |
| SG&A Expense | $274K | +124.5% |
| Operating Income | -$6.1M | -3113.1% |
| Net Income | -$6.1M | -3371.2% |
| EPS (Basic) | $0.00 | -100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $582K | +4351.3% |
| Current Assets | $1.6M | +5560.3% |
| Total Assets | $1.7M | +5901.7% |
| Current Liabilities | $98K | +108.2% |
| Total Liabilities | $129K | +173.8% |
| Stockholders' Equity | $1.6M | +8675.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -3724.1% |
| Investing Cash Flow | -$1.0M | — |
| Financing Cash Flow | $4.7M | +9480.6% |